Stock 300204 STAIDSON (BEIJING) BIOPHARMACEUTICALS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Staidson (Beijing) BioPharmaceuticals Co., Ltd.

Equities

300204

CNE100001237

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 08/05/2024 BST 		5-day change 1st Jan Change
7.08 CNY -4.58% Intraday chart for Staidson (Beijing) BioPharmaceuticals Co., Ltd. +5.99% -30.31%
04-24 Staidson BioPharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-25 Staidson BioPharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
InflaRx Announces Amendment of Co-Development Agreement and Additional Equity Investment by Staidson in Connection with Regulatory Filing in China for Anti-C5a-Antibody for Treatment of COVID-19
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 300204 Stock
  4. News Staidson (Beijing) BioPharmaceuticals Co., Ltd.
  5. Press Releases